- Title Pages
- Preface
- Acknowledgement
- Foreword
- Contributors
- Abbreviations
- Preamble to the second edition
- Chapter 1 Evolution of knowledge of the smoking epidemic
- Chapter 2 The great studies of smoking and disease in the twentieth century
- Chapter 3 Dealing with health fears: cigarette advertising in the United States in the twentieth century
- Chapter 4 Market manipulation: how the tobacco industry recruits and retains smokers
- Chapter 5 In their own words: an epoch of deceit and deception
- Chapter 6 The changing cigarette: chemical studies and bioassays
- Chapter 7 Tobacco carcinogenesis: mechanisms and biomarkers
- Chapter 8 Pharmacology of tobacco addiction
- Chapter 9 Manipulating product design to reinforce tobacco addiction
- Chapter 10 Nicotine content in tobacco and tobacco smoke
- Chapter 11 Tobacco smoking and tobacco-related harm in the European Union with special attention to the new EU member states
- Chapter 12 The epidemic in India
- Chapter 13 Tobacco—the growing epidemic<sup>*</sup>
- Chapter 14 Tobacco control in the Republic of South Korea, an Asian example
- Chapter 15 The hazards of smoking and the benefits of stopping: cancer mortality and overall mortality<sup>*</sup>
- Chapter 16 Passive smoking and health
- Chapter 17 Adolescent smoking
- Chapter 18 Tobacco and women
- Chapter 19 Cancer of the prostate
- Chapter 20 Laryngeal cancer
- Chapter 21 Smoking and cancer of the oesophagus
- Chapter 22 Tobacco use and risk of oral cancer
- Chapter 23 Smoking and stomach cancer
- Chapter 24 Cigarette smoking and colorectal cancer
- Chapter 25 Smoking and cervical neoplasia
- Chapter 26 Tobacco and pancreatic cancer
- Chapter 27 Smoking and lung cancer
- Chapter 28 Active and passive smoking and cancer of the breast
- Chapter 29 Smoking and ovarian cancer
- Chapter 30 Smoking, hormone concentrations, and endometrial cancer
- Chapter 31 Tobacco and cardiovascular disease
- Chapter 32 Chronic obstructive pulmonary disease
- Chapter 33 Smoking and other disorders
- Chapter 34 Interaction of tobacco with other risk factors
- Chapter 35 Roles of tobacco litigation in societal change
- Chapter 36 The adoption of smoke-free policies and their effectiveness
- Chapter 37 Advancing tobacco control by effective evaluation
- Chapter 38 Global tobacco control policy
- Chapter 39 Treatment of tobacco dependence
- Chapter 40 Tobacco harm reduction
- Chapter 41 Influencing politicians to implement comprehensive tobacco control: the power of news media
- Chapter 42 Origins and status of the WHO Framework Convention on Tobacco Control
- Chapter 43 WHO—coordinating international tobacco control
- Index
The adoption of smoke-free policies and their effectiveness
The adoption of smoke-free policies and their effectiveness
- Chapter:
- (p.623) Chapter 36 The adoption of smoke-free policies and their effectiveness
- Source:
- Tobacco
- Author(s):
Maria Leon-Roux
John P. Pierce
- Publisher:
- Oxford University Press
Leading health agencies have published authoritative reports evaluating the research on the health risks of second-hand smoke (SHS). There is a consensus across these reports that SHS (also called involuntary smoking) causes several diseases in non-smokers including lung cancer, heart disease, and both chronic and acute respiratory disease. The World Health Organization (WHO) negotiated the unprecedented Framework Convention on Tobacco Control (FCTC), the first ever public health treaty that achieved widespread support among member nations. Article 8 of the WHO FCTC focuses on the ‘protection from exposure to tobacco smoke’. Countries signing the treaty are required to implement policies to protect all people from exposure to SHS by law and not by means of voluntary agreements. To provide better clarification of the benefits of WHO FCTC compliant legislation, in April 2008, the International Agency for Research on Cancer (IARC) convened a group of seventeen scientists from nine countries in Lyon, France to assess the evidence for the effectiveness of smoke-free policies. The group proposed eleven potentially causal statements and summarized the strength of the evidence for each statement using the following five IARC classifications: sufficient, strong, limited, inadequate or no evidence and evidence of lack of an effect. This chapter presents a summary of that evidence and the main conclusions of the report.
Keywords: second-hand smoke, cigarette smoke, World Health Organization, Framework Convention on Tobacco Control, International Agency for Research on Cancer, anti-smoking policies, smoke-free policies
Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.
Please, subscribe or login to access full text content.
If you think you should have access to this title, please contact your librarian.
To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .
- Title Pages
- Preface
- Acknowledgement
- Foreword
- Contributors
- Abbreviations
- Preamble to the second edition
- Chapter 1 Evolution of knowledge of the smoking epidemic
- Chapter 2 The great studies of smoking and disease in the twentieth century
- Chapter 3 Dealing with health fears: cigarette advertising in the United States in the twentieth century
- Chapter 4 Market manipulation: how the tobacco industry recruits and retains smokers
- Chapter 5 In their own words: an epoch of deceit and deception
- Chapter 6 The changing cigarette: chemical studies and bioassays
- Chapter 7 Tobacco carcinogenesis: mechanisms and biomarkers
- Chapter 8 Pharmacology of tobacco addiction
- Chapter 9 Manipulating product design to reinforce tobacco addiction
- Chapter 10 Nicotine content in tobacco and tobacco smoke
- Chapter 11 Tobacco smoking and tobacco-related harm in the European Union with special attention to the new EU member states
- Chapter 12 The epidemic in India
- Chapter 13 Tobacco—the growing epidemic<sup>*</sup>
- Chapter 14 Tobacco control in the Republic of South Korea, an Asian example
- Chapter 15 The hazards of smoking and the benefits of stopping: cancer mortality and overall mortality<sup>*</sup>
- Chapter 16 Passive smoking and health
- Chapter 17 Adolescent smoking
- Chapter 18 Tobacco and women
- Chapter 19 Cancer of the prostate
- Chapter 20 Laryngeal cancer
- Chapter 21 Smoking and cancer of the oesophagus
- Chapter 22 Tobacco use and risk of oral cancer
- Chapter 23 Smoking and stomach cancer
- Chapter 24 Cigarette smoking and colorectal cancer
- Chapter 25 Smoking and cervical neoplasia
- Chapter 26 Tobacco and pancreatic cancer
- Chapter 27 Smoking and lung cancer
- Chapter 28 Active and passive smoking and cancer of the breast
- Chapter 29 Smoking and ovarian cancer
- Chapter 30 Smoking, hormone concentrations, and endometrial cancer
- Chapter 31 Tobacco and cardiovascular disease
- Chapter 32 Chronic obstructive pulmonary disease
- Chapter 33 Smoking and other disorders
- Chapter 34 Interaction of tobacco with other risk factors
- Chapter 35 Roles of tobacco litigation in societal change
- Chapter 36 The adoption of smoke-free policies and their effectiveness
- Chapter 37 Advancing tobacco control by effective evaluation
- Chapter 38 Global tobacco control policy
- Chapter 39 Treatment of tobacco dependence
- Chapter 40 Tobacco harm reduction
- Chapter 41 Influencing politicians to implement comprehensive tobacco control: the power of news media
- Chapter 42 Origins and status of the WHO Framework Convention on Tobacco Control
- Chapter 43 WHO—coordinating international tobacco control
- Index